Skip to content

Dairy and Plant Amino Acid Uptake. An Explorative Study

Dairy and Plant Amino Acid Uptake. An Explorative Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05813769
Acronym
DaPa
Enrollment
12
Registered
2023-04-14
Start date
2023-05-09
Completion date
2023-06-21
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amino Acid Plasma Profile

Keywords

Dairy protein, Plant protein, Postprandial plasma amino acid profiles, Essential amino acids (EAA), Total amino acids (AA)

Brief summary

To optimize the environmental sustainability, a protein transition to more plant-based protein sources is required. However, the protein quality of plant-based sources is lower than that of the dairy proteins casein and whey, which contain high levels of essential amino acids. The amino acid absorption characteristics of many plant-based proteins are unknown. The present study aims to estimate differences in postprandial plasma total essential amino acids (TEAA) profiles after protein consumption of different protein sources in blood of healthy participants. This explorative study has a randomized, cross-over, double-blind, controlled design.

Interventions

DIETARY_SUPPLEMENTDairy protein

During each visit, research subjects will receive the product dissolved in water, representing a 20g protein load.

DIETARY_SUPPLEMENTPlant protein

During each visit, research subjects will receive the product dissolved in water, representing a 20g protein load.

Sponsors

Wageningen University and Research
CollaboratorOTHER
FrieslandCampina
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Apparently healthy men and women; * Age ≥18 and ≤40 years; * Body mass index (BMI) ≥18.5 and ≤30 kg/m2 ; * Having veins suitable for blood sampling via a catheter (judged by study nurse/ medical doctor).

Exclusion criteria

* Any self-reported metabolic, gastrointestinal, inflammatory or chronic disease (such as anemia, diabetes, hepatitis, cardiovascular disease); * Having a history of medical or surgical events that may significantly affect the study outcome; * Anaemia (Haemoglobin (Hb) values \<7.5 mmol/L for women and \<8.5 mmol/L for men), as assessed by finger prick blood during screening visit; * Having a food or protein allergy * Use of glucose lowering drugs, insulin; * Use of medication that may impact gastric emptying (e.g. gastric acid inhibitors or laxatives); * Use of antibiotic treatment less than 1 month before start of the study and during the study; * Use of anti-depressives as a treatment for depression; * Use of protein supplements (must be stopped 1 week before the first test day); * Reported weight loss or weight gain of \> 3 kg in the month prior to pre-study screening, or intention to lose weight during the study period; * Reporting to follow or having planned a slimming or medically prescribed diet. * Not willing to keep a stable lifestyle during the study period; * Recent blood donation (\<1 month prior to test day 1 of the study) or not willing to stop donation during and 1 month after the study;

Design outcomes

Primary

MeasureTime frameDescription
Postprandial blood TEAA profilesFrome baseline up to 5 hours postprandialPostprandial plasma total essential amino acids (TEAA) profiles after protein consumption, determined by appearance in blood.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026